Joseph M. Frey

AstraZeneca (United States) — United States

Neuroscience · Life Sciences

12h-index993citations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuropeptides and Animal Physiology(6), Neuroscience and Neuropharmacology Research(5), Ion channel regulation and function(4), Receptor Mechanisms and Signaling(4), Nicotinic Acetylcholine Receptors Study(4)

Publications25 total

Mouse model predicts effects of smoking and varenicline on event-related potentials in humans
Nicotine & Tobacco Research·2010· 19 citedOpen Access
Working memory deficits predict short-term smoking resumption following brief abstinence
Drug and Alcohol Dependence·2009· 192 cited
Table of Contents
Biological Psychiatry·2008Open Access
Varenicline Improves Mood and Cognition During Smoking Abstinence
Biological Psychiatry·2008· 219 citedOpen Access
Validation of a paradigm for screening medications for nicotine dependence.
2007
Zaleplon and triazolam in humans: acute behavioral effects and abuse potential
Psychopharmacology·1999· 85 cited
Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure
Behavioural Pharmacology·1998· 23 cited
Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure
Psychopharmacology·1998· 9 cited
Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers
Behavioural Pharmacology·1997· 67 cited
Sodium channels and GABAA receptor-channel complex as targets of environmental toxicants
Toxicology Letters·1995· 47 cited
Sodium Channels and γ-Aminobutyric Acid Activated Channels as Target Sites of Insecticides
ACS symposium series·1995· 16 cited
Sodium and GABA-activated channels as the targets of pyrethroids and cyclodienes
Toxicology Letters·1992· 108 cited
Synthesis and biological activity of peptide hydroxamate inhibitors of degradation of substance P analogues
European Journal of Medicinal Chemistry·1992· 1 cited
Response of rat globus pallidus neurons to microiontophoretically applied μ and κ opioid receptor agonists
European Journal of Pharmacology·1989· 9 cited
Chronic haloperidol administration increases GABA binding and enhances neuronal responsiveness to iontophoresed GABA in rat globus pallidus
Brain Research·1989· 7 cited
A dehydro-keto-methylene inhibitor of substance P degradation
Peptides·1988
Gabaergic Mechanisms after Manipulation of Striatal Dopaminergic Neurons
Palgrave Macmillan UK eBooks·1988
DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY OF SELECTIVE AGONISTS FOR TACHYKININ RECEPTOR SUBTYPES
1987· 1 cited
CHARACTERIZATION OF A THIRD TACHYKININ RECEPTOR (SP-N) IN THE MAMMALIAN NERVOUS SYSTEM
1987
Behavioural effects of receptor-specific substance P agonists
Pain·1987· 131 cited
page 1 of 2Next →

Frequent Co-authors

Chaim Gilon(7), Zvi Selinger(7), Freda Patterson(5), Christopher Jepson(5), Andrew A. Strasser(5), Caryn Lerman(5), Ronald D. Huffman(5), R. Laufer(5), M. Chorev(5), Kenneth A. Perkins(4), Steven J. Siegel(4), James Loughead(3), Ruben C. Gur(3), Kenneth S. Ginsburg(3), Mary Louise Roy(3), Miriam Z. Mintzer(3), Maharaj K. Ticku(3), Dalia Papir-Kricheli(2), Ralph Laufer(2), Michael Chorev(2)